Pharmacokinetics and safety of the two oral cefaclor formulations in healthy chinese subjects in the fasting and postprandial states.

导出 LinkOut

翻译打印收藏纠错

作者： Xinyao,Qu ^[1] ; Qiaohuan,Deng ^[1] ; Ying,Li ^[2] ; Peng,Li ^[3] ; Guangwen,Liu ^[1] ; Yanli,Wang ^[1] ; Zhengzhi,Liu ^[1] ; Shuang,Yu ^[1] ; Yang,Cheng ^[1] ; Yannan,Zhou ^[1] ; Jiahui,Chen ^[1] ; Qing,Ren ^[1] ; Zishu,Yu ^[1] ; Zhengjie,Su ^[1] ; Yicheng,Zhao ^[4] ; Haimiao,Yang ^[1]

作者单位： Phase I Clinical Trial Laboratory, Affiliated Hospital of Changchun University of Chinese Medicine, Jilin, China. ^[1] Disha Pharmaceutical Group Co., Ltd., Shanghai, China. ^[2] Shanghai Xihua Scientific Co., Ltd., Shanghai, China. ^[3] Puheng Technology Co., Ltd., Suzhou, China. ^[4]

关键词 antibiotic cefaclor cephalosporin equivalence pharmacokinetic

DOI 10.3389/fphar.2022.1012294

PMID 36278160

发布时间 2022-10-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in pharmacology

2022年13卷

1012294页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Pharmacokinetics and safety of the two oral cefaclor formulations in healthy chinese subjects in the fasting and postprandial states.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Pharmacokinetics and safety of the two oral cefaclor formulations in healthy chinese subjects in the fasting and postprandial states.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除